APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. - Wikidata - awgldk - TriplyDB

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.

http://www.wikidata.org/entity/Q30250088

about

Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy.Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy.Hepatitis C treatment from "response-guided" to "resource-guided" therapy in the transition era from interferon-containing to interferon-free regimens.The oncologic burden of hepatitis C virus infection: A clinical perspective.Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan.Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples - a systematic review and meta-analysis.Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.Genetic variations in NF-κB were associated with the susceptibility to hepatitis C virus infection among Chinese high-risk population.Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population.Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.Hepatitis C in Pregnancy.Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

P2860

Q36258800-42804E42-EA98-45E2-AD63-AE9FD07F1ADB Q37578288-AA9A0E65-43E4-4A71-A991-862AEC52CFDC Q39032538-DB7EE8CE-FC1E-4428-9966-9A32D1448C6F Q39104215-1E7E76BC-AF58-455D-8CA1-B911467E9031 Q39418450-572BB4D1-2EED-4F28-A81F-C4E7C5DF435C Q40178123-46431C4C-8FFD-45C6-85F7-1845E7D99E75 Q47128327-8D435C55-F02B-480E-A4A2-1E294D98BD07 Q47132671-10DC1917-DD4C-4AB7-92FD-0A46ED550FFA Q47274792-C51B1E22-9A7A-4C3C-ABE0-CBF39BF48AB6 Q47557031-6135E454-C8AC-4040-931A-7247A2533F3A Q47561355-F1289AA1-235B-48B1-802C-BFA0E74C9062 Q47631237-7294B2CC-E1D3-416C-A4EF-B54E5005D09E Q54226744-7B5A1C75-AD04-4017-8440-A3EDEAAC0E5D Q58593930-3D5E3F23-D157-465D-BB03-AC2D636A5AD8 Q58788714-7F78F9D6-AB55-4D42-9EA4-E0E00699991D

P2860

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.

http://www.wikidata.org/entity/Q30250088

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

APASL consensus statements and ...... ology, and laboratory testing.

@ast

APASL consensus statements and ...... ology, and laboratory testing.

@en

type

label

APASL consensus statements and ...... ology, and laboratory testing.

@ast

APASL consensus statements and ...... ology, and laboratory testing.

@en

prefLabel

APASL consensus statements and ...... ology, and laboratory testing.

@ast

APASL consensus statements and ...... ology, and laboratory testing.

@en

P1433

Q30250088-62A588FE-98C9-461F-A689-21237FDE6AAC

P1476

Q30250088-3C0164C2-3159-48CF-ABEA-E248FDF64D4C

P2093

Q30250088-067F235D-7419-46B0-9AAD-A4ED57B58200

Q30250088-1037A336-CEC2-4F8F-8DC4-4208DF9C0132

Q30250088-1573C0F9-380F-4D5F-AD8B-371443479993

Q30250088-18029CAC-681A-435E-8A1F-D87D62D7775D

Q30250088-26131A39-5899-42C7-8C5F-212DCA9D399C

Q30250088-3189B818-46C5-47AA-9B82-EEE2464412FC

Q30250088-33318740-0617-4B25-B665-57E505AA3CF2

Q30250088-43FEF385-6F79-4D4B-93EB-05136C05D8E6

Q30250088-465C7BF1-596A-4CBD-995D-1C96D9985E27

Q30250088-651BC833-0898-4DE9-9B98-372FE6121CC0

P275

Q30250088-D53D5DCA-7D7F-4E2A-9B3F-FBE8A0DF351D

P2860

Q30250088-0025EF54-8602-4377-B618-376001549E2C

Q30250088-0116BF93-FA79-4EDD-B0C2-748DF7044B88

Q30250088-024299F5-FEBC-450C-8A61-CA4F2C54A8A2

Q30250088-0592946A-BA20-4462-9535-B11010B5A413

Q30250088-06AD74DE-2106-43C4-ABBE-07FBF507CCC4

Q30250088-072938A5-488B-4E58-ACE9-E95EFD220BB8

Q30250088-09E86548-CBCA-4DE0-B2EF-1E064C1EA79B

Q30250088-0A40DF2D-000E-490F-8F0C-08E03064DAC8

Q30250088-0A49C3E7-B85E-44D0-B008-6044EB71B7E8

Q30250088-0C4DF094-8A5D-4634-9706-376B42EF95DA

P2888

Q30250088-57DDB9B3-0734-4F35-ACC3-0E5EF7BC1546

P304

Q30250088-0B589602-7193-46FB-91E5-A0240BE87691

P31

Q30250088-343fc892-c02c-45ed-9bc8-c748b3624103

Q30250088-55FD22DD-5386-4238-AAAF-14B4DAB6E04D

P356

Q30250088-F30FB673-40E7-48AE-9320-B7F45D958A28

P433

Q30250088-7A8AA373-885C-4C57-978F-70BE936325D8

P478

Q30250088-DD25794D-C8AF-495E-9FB1-60794933D5BB

P50

Q30250088-027EF0FE-9B70-4BE6-8957-56CD02955EC7

Q30250088-E7940BFF-D61E-4289-B710-87D250B64561

P5008

Q30250088-18620D24-DD0A-419C-BEC9-3AD6B5A6EC27

P577

Q30250088-ADD86765-3D7F-4E97-97D6-797DA0EF28B1

P6179

Q30250088-538957A1-166F-410A-BB1E-F35670CC9B67

P698

Q30250088-F2F86E78-574C-4F55-B758-2113E264ECAF

P921

Q30250088-8B2CB43A-674A-442F-A5A4-07D44D0E94BE

P932

Q30250088-C8664689-FC5D-4182-A0C3-ED1ACD55FEFC

P356

S12072-016-9736-3

P1433

Hepatology international

P1476

APASL consensus statements and ...... iology, and laboratory testing

@en

P2093

A Kadir Dokmeci

http://www.w3.org/2001/XMLSchema#string

Alaaeldin Ibrahim

http://www.w3.org/2001/XMLSchema#string

Ankur Jindal

http://www.w3.org/2001/XMLSchema#string

Barjesh Chander Sharma

http://www.w3.org/2001/XMLSchema#string

Cosmas Rinaldi Adithya Lesmana

http://www.w3.org/2001/XMLSchema#string

Darrell H G Crawford

http://www.w3.org/2001/XMLSchema#string

Geofferey W McCaughan

http://www.w3.org/2001/XMLSchema#string

George K K Lau

http://www.w3.org/2001/XMLSchema#string

Jafri Wasim

http://www.w3.org/2001/XMLSchema#string

Jose Sollano

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

Global epidemiology and genotype distribution of the hepatitis C virus infection

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Specific Polymorphisms in Hepatitis C Virus Genotype 3 Core Protein Associated with Intracellular Lipid Accumulation

Recombinant adenoviruses expressing Steatosis-associated Hepatitis C virus genotype 3 Core protein produce intracellular lipid accumulation in cultured and primary hepatocytes

Quantification of Hepatitis C Virus (HCV) RNA in a Multicenter Study: Implications for Management of HCV Genotype 1-Infected Patients

P2888

s12072-016-9736-3

P304

681-701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-016-9736-3

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Shiv Kumar Sarin

P5008

P577

2016-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010129254

http://www.w3.org/2001/XMLSchema#string

P698

27229718

http://www.w3.org/2001/XMLSchema#string

P921

P932

5003900

http://www.w3.org/2001/XMLSchema#string